Henoch-Schönlein purpura following hepatitis B vaccination
- PMID: 14522629
- DOI: 10.1080/09546630310004199
Henoch-Schönlein purpura following hepatitis B vaccination
Abstract
The use of recombinant hepatitis B vaccines has led to the effective prevention of hepatitis B infection and its chronic sequelae in immunocompetent individuals. Whilst rare, a variety of serious adverse effects have been reported following vaccination including cutaneous vasculitis in eight previous cases. We describe a case of Henoch-Schönlein purpura developing after hepatitis B vaccination.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources